All In MedTech

Device Trial Radar · NCT07824583

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

A ProSPEctivE Study of NGDS DMAT Workflow Feasibility

Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Jul 31, 2026

Primary completion

Feb 2027

Study completion May 2027

Sponsor

Lead sponsor
Varian, a Siemens Healthineers CompanyNot on our public-company list
Sponsor type
Industry
First posted
Sep 17, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research is to evaluate the "Next Generation Delivery System" (NGDS) and determine if this machine will be more efficient at delivering radiation in shorter treatment time and better patient tolerance, with less breath holding.

Conditions

  • Lung Cancer (Diagnosis)
  • Liver Cancer, Adult
  • Pancreatic Cancer
  • Thoracic Cancers
  • Abdominal Cancer

Interventions

  • Next Generation Delivery System (NGDS)Device

    Participant will receive a "mock" treatment on the NGDS machine. Participant will complete experience questionnaires.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the feasibility of the mock NGDS DMAT workflow under breath hold conditions.Time frame: From enrollment to end of "mock" treatment of last participant enrolled, assessed up to 6 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Siteman Cancer Center Washington University

    St Louis, Missouri · Recruiting

  • University Hospital Cleveland Medical Center

    Cleveland, Ohio · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.